Class information for:
Level 2: TUMOR DORMANCY//DORN VA MED//CONCOMITANT RESISTANCE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2793 2583 33.4 47%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
198 48841 CELLULAR IMMUNOLOGY//THYMOSIN BETA 4//INTERLEUKIN 2

Classes in level below (level 1)


ID, lev. below Publications Label for level below
8478 1180 TUMOR BEARING STATE//AUTOIMMUNOTHERAPY//CD8 CELL REACTIVITY
16421 589 ANTIGEN SHEDDING//ADOPTIVE CHEMOIMMUNOTHERAPY//DRUG RESISTANT TUMORS
20474 397 DORN VA MED//TUMOR DORMANCY//CONCOMITANT RESISTANCE
30513 137 GRANULOMA MODULATION//REFERENZZENTRUM KRANKENHAUSHYG//ANTI HAMSTER T CELL MAB
31124 127 ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING
32790 102 MU MSV//CLA PTX//EPIDERMIS PROLIFERATION
35135 51 DITHIONITROBENZOATE//IGG BLOOD//YOSHIDA HEPATOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TUMOR DORMANCY Author keyword 12 29% 1% 34
2 DORN VA MED Address 12 86% 0% 6
3 CONCOMITANT RESISTANCE Author keyword 8 70% 0% 7
4 TUMOR BEARING STATE Author keyword 4 67% 0% 4
5 METASTASIS DEVELOPMENT Author keyword 4 75% 0% 3
6 TUMOUR DORMANCY Author keyword 4 36% 0% 8
7 ANTIGEN SHEDDING Author keyword 2 36% 0% 5
8 ADOPTIVE CHEMOIMMUNOTHERAPY Author keyword 2 67% 0% 2
9 CONCOMITANT TUMOR RESISTANCE Author keyword 2 67% 0% 2
10 DRUG RESISTANT TUMORS Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TUMOR DORMANCY 12 29% 1% 34 Search TUMOR+DORMANCY Search TUMOR+DORMANCY
2 CONCOMITANT RESISTANCE 8 70% 0% 7 Search CONCOMITANT+RESISTANCE Search CONCOMITANT+RESISTANCE
3 TUMOR BEARING STATE 4 67% 0% 4 Search TUMOR+BEARING+STATE Search TUMOR+BEARING+STATE
4 METASTASIS DEVELOPMENT 4 75% 0% 3 Search METASTASIS+DEVELOPMENT Search METASTASIS+DEVELOPMENT
5 TUMOUR DORMANCY 4 36% 0% 8 Search TUMOUR+DORMANCY Search TUMOUR+DORMANCY
6 ANTIGEN SHEDDING 2 36% 0% 5 Search ANTIGEN+SHEDDING Search ANTIGEN+SHEDDING
7 ADOPTIVE CHEMOIMMUNOTHERAPY 2 67% 0% 2 Search ADOPTIVE+CHEMOIMMUNOTHERAPY Search ADOPTIVE+CHEMOIMMUNOTHERAPY
8 CONCOMITANT TUMOR RESISTANCE 2 67% 0% 2 Search CONCOMITANT+TUMOR+RESISTANCE Search CONCOMITANT+TUMOR+RESISTANCE
9 DRUG RESISTANT TUMORS 2 67% 0% 2 Search DRUG+RESISTANT+TUMORS Search DRUG+RESISTANT+TUMORS
10 INAPPROPRIATE GENE EXPRESSION 2 67% 0% 2 Search INAPPROPRIATE+GENE+EXPRESSION Search INAPPROPRIATE+GENE+EXPRESSION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CONCOMITANT RESISTANCE 24 91% 0% 10
2 TUMOR DORMANCY 12 29% 1% 35
3 NONIMMUNOGENIC MURINE TUMORS 11 100% 0% 6
4 FREE THIOL GROUPS 11 69% 0% 9
5 HUMAN LIPOSARCOMA 11 69% 0% 9
6 LABILE DISULFIDE BONDS 8 75% 0% 6
7 LARGE MOPC 315 TUMOR 8 56% 0% 10
8 IA RESTRICTED INTERACTION 6 80% 0% 4
9 CANCER DORMANCY 6 40% 0% 12
10 IGG2 SUBCLASSES 6 100% 0% 4

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
ADOPTIVE T-CELL THERAPY OF TUMORS - MECHANISMS OPERATIVE IN THE RECOGNITION AND ELIMINATION OF TUMOR-CELLS 1991 533 289 18%
The epigenetic/noncoding origin of tumor dormancy 2015 1 64 23%
DOWN-REGULATION OF THE ANTITUMOR IMMUNE-RESPONSE 1985 173 60 65%
EFFECTS OF ANTICANCER DRUGS ON THE IMMUNE-SYSTEM IN HUMANS 1989 70 61 75%
The effects of surgery on tumor growth: a century of investigations 2008 76 55 45%
Mechanisms of disseminated cancer cell dormancy: an awakening field 2014 18 143 18%
TUMOR-ERADICATION BY ADOPTIVE TRANSFER OF CYTOTOXIC T-LYMPHOCYTES 1992 237 194 20%
Does tumour dormancy offer a therapeutic target? 2010 97 68 34%
Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? 2005 73 26 35%
TOWARD A GENETIC-ANALYSIS OF TUMOR REJECTION ANTIGENS 1992 125 84 30%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DORN VA MED 12 86% 0.2% 6
2 STEWARD SPECIALTY PROJECTS CORP 2 50% 0.1% 3
3 ESTUDIOS ONCOL 1 16% 0.3% 7
4 CUALTOS 1 30% 0.1% 3
5 EXCELLENCE CANC GENOM 1 30% 0.1% 3
6 DORN VET AFFAIRS MED 1 40% 0.1% 2
7 BIOL IMAGING CELL BIOL PHYSIOL 1 50% 0.0% 1
8 BIOSTAT BRANCHEPSNIH 1 50% 0.0% 1
9 BIOSTAT BRANCHNIH 1 50% 0.0% 1
10 CANC SYST BIOLST ELIZABETHS MED 1 50% 0.0% 1

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000033237 INTERLEUKIN 2//GRANZYME B//PERFORIN
2 0.0000029491 P15E//IMMUNE SUPPRESSOR CELLS//IRX 2
3 0.0000021510 EOSINOPHIL CHEMOTACTIC FACTOR//LEUKOREGULIN//RYBINSK RESERVOIR
4 0.0000020828 UKRAIN//ANTITUMOR RESISTANCE//RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL
5 0.0000020303 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180
6 0.0000018969 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY
7 0.0000018389 ST PETERSBURG BIOREGULAT GERONTOL//HISTORY OF CHROMATOGRAPHY//EPITHALON
8 0.0000013897 THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR
9 0.0000010446 IMEXON//LEVAMISOLE//TYROSERLEUTIDE
10 0.0000009103 TISSUE ANTIGENS//IMMUNOGENETICS//HUMAN IMMUNOLOGY